NKTR
Nektar Therapeutics
42.20$
-3.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| -17.4% | – | – | – | 205.7% | 5.4% | 7.4% | 13.8% | 17.3% | 28.5% | 54.2% | 54.0% | 38.9% | 43.0% | 16.1% | 30.6% | 37.5% | 25.9% | 14.2% | 14.8% | 18.3% | 9.9% | 2.0% | 18.6% | 12.7% | 24.4% | 23.5% | 40.7% | 31.2% | 0.0% | |
| 117.4% | 100.0% | 100.0% | 100.0% | 100.0% | 94.6% | 92.6% | 86.2% | 82.7% | 71.5% | 45.8% | 46.0% | 61.1% | 57.0% | 83.9% | 69.4% | 62.5% | 74.1% | 85.8% | 85.2% | 81.7% | 90.1% | 98.0% | 81.4% | 87.3% | 75.6% | 76.5% | 59.3% | 68.8% | 100.0% | |
| 208.7% | 145.5% | 162.4% | 154.9% | 196.7% | 180.3% | 165.9% | 123.8% | 116.8% | 120.1% | 68.6% | 56.2% | 171.2% | 132.2% | 67.9% | 177.3% | 183.1% | 127.6% | 73.6% | 79.2% | 123.2% | 87.2% | 33.5% | 379.1% | 267.3% | 392.8% | 237.2% | 126.7% | 122.8% | 212.4% | |
| 58.0% | 38.9% | 38.5% | 19.0% | 27.0% | 24.3% | 27.4% | 20.7% | 27.1% | 34.7% | 36.0% | 20.6% | 57.1% | 57.0% | 25.8% | 65.4% | 51.3% | 27.2% | 20.4% | 18.7% | 26.8% | 17.0% | 6.8% | 86.1% | 68.5% | 120.5% | 100.3% | 85.9% | 78.0% | 124.3% | |
| 284.1% | 184.5% | 200.9% | 174.0% | 223.7% | 237.5% | 198.1% | 148.5% | 147.4% | 209.9% | 118.9% | 59.2% | 152.8% | 189.2% | 93.7% | 242.8% | 234.4% | 154.8% | 94.0% | 98.0% | 150.0% | 104.3% | 40.3% | 465.3% | 335.7% | 513.3% | 337.5% | 211.8% | 175.7% | 336.8% | |
| -166.7% | -84.5% | -100.9% | -97.9% | -128.1% | -331.7% | -105.5% | -62.3% | -64.7% | -144.6% | -73.1% | -13.2% | -91.6% | -132.3% | -17.8% | -173.4% | -173.9% | -80.7% | -8.2% | -12.7% | -68.2% | -19.4% | 57.6% | -383.9% | -248.5% | -437.8% | -261.0% | -152.5% | -106.9% | -236.8% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 23.5% | 17.3% | 17.5% | 16.8% | 22.5% | 11.2% | 9.3% | 6.8% | 16.8% | 16.9% | 7.0% | 14.3% | 41.3% | 27.4% | 19.3% | 16.9% | 25.5% | 13.3% | 3.6% | 40.4% | 24.3% | 46.4% | 31.4% | 28.1% | 28.6% | 47.4% | |
| -143.5% | – | – | -121.8% | -188.7% | -322.7% | -113.3% | -43.8% | -89.3% | -146.7% | -70.7% | -11.5% | 39.0% | -142.9% | -23.3% | -186.0% | -211.2% | -107.3% | -27.1% | -35.0% | -92.3% | -31.2% | 57.2% | -383.9% | -290.3% | -513.5% | -396.5% | -306.5% | -121.1% | -297.3% | |
| -21.7% | -23.0% | -16.7% | 19.0% | 65.0% | 179.8% | 7.8% | 0.2% | -0.1% | -0.1% | 0.4% | 0.5% | -0.9% | -0.4% | 0.6% | 1.4% | 0.5% | 1.5% | -0.3% | 0.2% | 0.5% | 0.2% | 0.1% | 0.5% | 0.3% | 0.5% | 3.5% | -0.2% | -0.2% | -0.2% | |
| -144.9% | -61.4% | -84.2% | -93.0% | -188.7% | -322.7% | -113.3% | -43.9% | -89.2% | -146.6% | -71.1% | -12.0% | -38.1% | -142.5% | -23.9% | -187.4% | -211.7% | -108.8% | -26.9% | -35.2% | -92.8% | -31.4% | 57.1% | -384.5% | -290.6% | -514.0% | -400.0% | -306.3% | -120.9% | -297.1% | |
| -149.3% | -69.5% | -84.4% | -56.4% | -104.1% | -90.8% | -85.5% | -45.0% | -47.9% | -116.5% | -57.7% | -2.6% | 2.8% | -105.3% | -5.9% | -150.8% | -152.9% | -71.2% | -1.4% | -12.7% | -58.8% | -13.8% | 61.5% | -333.9% | -257.9% | -453.2% | -351.8% | -269.8% | -88.1% | -248.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.